Last week, UnitedHealth Group Inc. (UNH) reported its first-quarter results surpassed Wall Street analysts’ expectations.
Revenues for UnitedHealth Group rose 9% to $ 70.2 billion in the first quarter. GAAP net income for the company was $ 4.9 billion, which corresponded to a profit per share of $5.08 per share. Adjusted net income reached $ 5.31 per share. The price per share was $3.72 a year earlier.
UnitedHealth Group’s health insurance segment provided the bulk of the company’s revenues in the last quarter when revenue grew by almost 8 % year-on-year to $ 55 billion. The COVID-19 pandemic increased treatment costs even though patient numbers grew. Nevertheless, the company was still able to stabilize the contribution and benefit size by maintaining costs of planned treatment below standard indicators.
For the first quarter, more than one million additional people registered for UnitedHealthcare programs.
Optum Health was a critical force in accelerating growth, growing 31 % YoY in revenue per customer in the first quarter.
In the past quarter, the pharmaceutical benefit management division of OptumRx was worth 21.6 billion dollars to UnitedHealth Group.
UnitedHealth Group (UNH) increased its full-year outlook based on strong first-quarter results. The earnings per share range will range from $ 17.15 to $ 17.65. Adjusted earnings per share are expected to range from $ 18.1 to $ 18.6.
Despite the COVID-19 pandemic when the cost of emergency medical care was growing, and the healthcare system struggled to organize work, UnitedHealth has continued to demonstrate its resilience. The likely expansion of Medicaid and Medicare coverage and the availability of the COVID-19 vaccine will benefit UnitedHealth Group.
UnitedHealth Group Inc. (UNH) stock gained 0.26% to close the last trading session at $391.01. Its trading volume was 4.53 million shares, higher than its average daily trading volume in the previous 50 days of 3.47 million shares. Even though UnitedHealth Group Incorporated was up 3.91% in the last five days, they were up 11.03% last month. The stock price has added 11.55% in the previous three months and has gained 11.50% this year. Also, it has a price to cash flow ratio of 23.44. It has a price to sales ratio of 1.40, and its price to earnings ratio is 22.23.